Literature DB >> 18189345

Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.

Habtom W Ressom1, Rency S Varghese, Lenka Goldman, Yanming An, Christopher A Loffredo, Mohamed Abdel-Hamid, Zuzana Kyselova, Yehia Mechref, Milos Novotny, Steven K Drake, Radoslav Goldman.   

Abstract

This paper presents computational methods to analyze MALDI-TOF mass spectrometry data for quantitative comparison of peptides and glycans in serum. The methods are applied to identify candidate biomarkers in serum samples of 203 participants from Egypt; 73 hepatocellular carcinoma (HCC) cases, 52 patients with chronic liver disease (CLD) consisting of cirrhosis and fibrosis cases, and 78 population controls. Two complementary sample preparation methods were applied prior to generating mass spectra: (1) low molecular weight (LMW) enrichment of each serum sample was carried out for MALDI-TOF quantification of peptides, and (2) glycans were enzymatically released from proteins in each serum sample and permethylated for MALDI-TOF quantification of glycans. A peak selection algorithm was applied to identify the most useful peptide and glycan peaks for accurate detection of HCC cases from high-risk population of patients with CLD. In addition to global peaks selected by the whole population based approach, where identically labeled patients are treated as a single group, subgroup-specific peaks were identified by searching for peaks that are differentially abundant in a subgroup of patients only. The peak selection process was preceded by peak screening, where we eliminated peaks that have significant association with covariates such as age, gender, and viral infection based on the peptide and glycan spectra from population controls. The performance of the selected peptide and glycan peaks was evaluated in terms of their ability in detecting HCC cases from patients with CLD in a blinded validation set and through the cross-validation method. Finally, we investigated the possibility of using both peptides and glycans in a panel to enhance the diagnostic capability of these candidate markers. Further evaluation is needed to examine the potential clinical utility of the candidate peptide and glycan markers identified in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189345      PMCID: PMC2268625          DOI: 10.1021/pr0705237

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  24 in total

1.  Analysis of mass spectral serum profiles for biomarker selection.

Authors:  Habtom W Ressom; Rency S Varghese; Mohamed Abdel-Hamid; Sohair Abdel-Latif Eissa; Daniel Saha; Lenka Goldman; Emanuel F Petricoin; Thomas P Conrads; Timothy D Veenstra; Christopher A Loffredo; Radoslav Goldman
Journal:  Bioinformatics       Date:  2005-09-13       Impact factor: 6.937

Review 2.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

3.  Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.

Authors:  Eduard Orvisky; Steven K Drake; Brian M Martin; Mohamed Abdel-Hamid; Habtom W Ressom; Rency S Varghese; Yanming An; Daniel Saha; Glen L Hortin; Christopher A Loffredo; Radoslav Goldman
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

4.  Peak selection from MALDI-TOF mass spectra using ant colony optimization.

Authors:  H W Ressom; R S Varghese; S K Drake; G L Hortin; M Abdel-Hamid; C A Loffredo; R Goldman
Journal:  Bioinformatics       Date:  2007-01-19       Impact factor: 6.937

5.  N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.

Authors:  Jia Zhao; Weilian Qiu; Diane M Simeone; David M Lubman
Journal:  J Proteome Res       Date:  2007-01-24       Impact factor: 4.466

6.  Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Melissa Lowman; Ronald E Long; Jonathan Krakover; Ramila Philip; Steven Seeholzer; Alison A Evans; Hie-Won L Hann; Timothy M Block; Anand S Mehta
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

7.  Alterations in the serum glycome due to metastatic prostate cancer.

Authors:  Zuzana Kyselova; Yehia Mechref; Mohammad M Al Bataineh; Lacey E Dobrolecki; Robert J Hickey; Jake Vinson; Christopher J Sweeney; Milos V Novotny
Journal:  J Proteome Res       Date:  2007-04-14       Impact factor: 4.466

8.  Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.

Authors:  John M Luk; Chi-Tat Lam; Annie F M Siu; Brian Y Lam; Irene O L Ng; Mei-Yu Hu; Chi-Ming Che; Sheung-Tat Fan
Journal:  Proteomics       Date:  2006-02       Impact factor: 3.984

9.  Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

Authors:  I-Neng Lee; Chien-Hung Chen; Jin-Chuan Sheu; Hsuan-Shu Lee; Guan-Tarn Huang; Ding-Shinn Chen; Chen-Yin Yu; Chu-Ling Wen; Fung-Jou Lu; Lu-Ping Chow
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

10.  Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.

Authors:  D G Ward; Y Cheng; G N'Kontchou; T T Thar; N Barget; W Wei; L J Billingham; A Martin; M Beaugrand; P J Johnson
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

View more
  21 in total

1.  Delineating diseases by IMS-MS profiling of serum N-linked glycans.

Authors:  Dragan Isailovic; Manolo D Plasencia; Maissa M Gaye; Sarah T Stokes; Ruwan T Kurulugama; Vitara Pungpapong; Min Zhang; Zuzana Kyselova; Radoslav Goldman; Yehia Mechref; Milos V Novotny; David E Clemmer
Journal:  J Proteome Res       Date:  2011-12-30       Impact factor: 4.466

2.  Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.

Authors:  William R Alley; Milos V Novotny
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

3.  Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach.

Authors:  L Veillon; S Zhou; Y Mechref
Journal:  Methods Enzymol       Date:  2017-01-09       Impact factor: 1.600

Review 4.  Mass spectrometry and glycomics.

Authors:  Joseph Zaia
Journal:  OMICS       Date:  2010-08

5.  Delineation of disease phenotypes associated with esophageal adenocarcinoma by MALDI-IMS-MS analysis of serum N-linked glycans.

Authors:  M M Gaye; T Ding; H Shion; A Hussein; Y Hu; S Zhou; Z T Hammoud; B K Lavine; Y Mechref; J C Gebler; D E Clemmer
Journal:  Analyst       Date:  2017-05-02       Impact factor: 4.616

Review 6.  Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

Authors:  Jianhui Zhu; Elisa Warner; Neehar D Parikh; David M Lubman
Journal:  Mass Spectrom Rev       Date:  2018-11-25       Impact factor: 10.946

Review 7.  Glycans and glycoproteins as specific biomarkers for cancer.

Authors:  Muchena J Kailemia; Dayoung Park; Carlito B Lebrilla
Journal:  Anal Bioanal Chem       Date:  2016-09-03       Impact factor: 4.142

8.  Pancreatic cancer serum detection using a lectin/glyco-antibody array method.

Authors:  Chen Li; Diane M Simeone; Dean E Brenner; Michelle A Anderson; Kerby A Shedden; Mack T Ruffin; David M Lubman
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

9.  Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.

Authors:  Zhiqun Tang; Rency S Varghese; Slavka Bekesova; Christopher A Loffredo; Mohamed Abdul Hamid; Zuzana Kyselova; Yehia Mechref; Milos V Novotny; Radoslav Goldman; Habtom W Ressom
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

10.  The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.

Authors:  Scott R Kronewitter; Hyun Joo An; Maria Lorna de Leoz; Carlito B Lebrilla; Suzanne Miyamoto; Gary S Leiserowitz
Journal:  Proteomics       Date:  2009-06       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.